These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 34703500)

  • 1. The utility of endogenous glycochenodeoxycholate-3-sulfate and 4β-hydroxycholesterol to evaluate the hepatic disposition of atorvastatin in rats.
    Ma Y; Xin M; Wen Y; Wang H; Zhang G; Dai J; Wu XA
    Asian J Pharm Sci; 2021 Jul; 16(4):519-529. PubMed ID: 34703500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems.
    Lau YY; Okochi H; Huang Y; Benet LZ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):762-71. PubMed ID: 16258024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
    Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
    AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers.
    Takehara I; Terashima H; Nakayama T; Yoshikado T; Yoshida M; Furihata K; Watanabe N; Maeda K; Ando O; Sugiyama Y; Kusuhara H
    Pharm Res; 2017 Aug; 34(8):1601-1614. PubMed ID: 28550384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of CYP3A-specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β-hydroxycholesterol/cholesterol ratio.
    Lee J; Fallon JK; Smith PC; Jackson KD
    Clin Transl Sci; 2023 Feb; 16(2):279-291. PubMed ID: 36350327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
    Li K; Zhao S; Zhang L; Wu X; Shu P; Wang Y; Feng H; Gu Z; Han Hsu H
    Drug Metab Dispos; 2014 May; 42(5):839-43. PubMed ID: 24595680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beverage-Drug Interaction: Effects of Green Tea Beverage Consumption on Atorvastatin Metabolism and Membrane Transporters in the Small Intestine and Liver of Rats.
    Yao HT; Hsu YR; Li ML
    Membranes (Basel); 2020 Sep; 10(9):. PubMed ID: 32937767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment.
    Kim AH; Yoon S; Lee Y; Lee J; Bae E; Lee H; Kim DK; Lee S; Yu KS; Jang IJ; Cho JY
    J Korean Med Sci; 2018 Dec; 33(53):e298. PubMed ID: 30595680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1β-Hydroxydeoxycholic Acid as an Endogenous Biomarker in Human Plasma for Assessment of CYP3A Clinical Drug-Drug Interaction Potential.
    Xue Y; Wang L; Huo R; Chen M; Melo B; Dingley K; Gaudy A; Shen JX
    Drug Metab Dispos; 2024 Aug; 52(9):966-974. PubMed ID: 38991779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
    Aubry AF; Dean B; Diczfalusy U; Goodenough A; Iffland A; McLeod J; Weng N; Yang Z
    AAPS J; 2016 Sep; 18(5):1056-1066. PubMed ID: 27350147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Inhibition of the Distribution of Lobeglitazone to the Liver by Atorvastatin in Rats: Evidence for a Rat Organic Anion Transporting Polypeptide 1B2-Mediated Interaction in Hepatic Transport.
    Yim CS; Jeong YS; Lee SY; Pyeon W; Ryu HM; Lee JH; Lee KR; Maeng HJ; Chung SJ
    Drug Metab Dispos; 2017 Mar; 45(3):246-259. PubMed ID: 28069721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Prediction of Drug-Drug Interactions Caused by CYP3A Induction Using Endogenous Biomarker 4
    Takubo H; Taniguchi T; Nomura Y
    Drug Metab Dispos; 2024 Nov; 52(12):1438-1444. PubMed ID: 39389625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides.
    Thakare R; Gao H; Kosa RE; Bi YA; Varma MVS; Cerny MA; Sharma R; Kuhn M; Huang B; Liu Y; Yu A; Walker GS; Niosi M; Tremaine L; Alnouti Y; Rodrigues AD
    Drug Metab Dispos; 2017 Jul; 45(7):721-733. PubMed ID: 28396527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in Dogs.
    Liu R; Ma B; Mok MM; Murray BP; Subramanian R; Lai Y
    Drug Metab Dispos; 2024 Feb; 52(3):236-241. PubMed ID: 38123963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine.
    Naito T; Kubono N; Ishida T; Deguchi S; Sugihara M; Itoh H; Kanayama N; Kawakami J
    Drug Metab Pharmacokinet; 2015 Dec; 30(6):419-24. PubMed ID: 26654672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.
    Mao J; Martin I; McLeod J; Nolan G; van Horn R; Vourvahis M; Lin YS
    Drug Metab Rev; 2017 Feb; 49(1):18-34. PubMed ID: 27718639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.
    Penzak SR; Rojas-Fernandez C
    J Clin Pharmacol; 2019 May; 59(5):611-624. PubMed ID: 30748026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations.
    Björkhem-Bergman L; Nylén H; Eriksson M; Parini P; Diczfalusy U
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):499-502. PubMed ID: 26617265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Analysis of the Transporter-Mediated Drug-Drug Interaction Between Atorvastatin and Rifampicin Using a Stable Isotope-IV Method.
    Yamashita S; Hasegawa T; Tachihara M; Minami K; Higashino H; Togashi K; Mutaguchi K; Kataoka M
    J Pharm Sci; 2017 Sep; 106(9):2671-2677. PubMed ID: 28457720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.